No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
ADX-47273 is a drug used to treat central nervous system (CNS) disorders. It is a small molecule inhibitor of the enzyme phosphodiesterase-4 (PDE4), which is involved in the regulation of inflammation and neurotransmitter release. ADX-47273 has been studied for its potential to treat a variety of CNS disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and depression. It has also been studied for its potential to treat neuropathic pain.
ADX-47273 is currently in clinical trials and has not yet been approved for use in humans. However, it has shown promise in preclinical studies and is being developed by several pharmaceutical companies. Companies involved in the development of ADX-47273 include Adare Pharmaceuticals, AstraZeneca, and Merck. Show Less Read more
